Son güncelleme: Ağustos 17, 2026
Rusya'da ilaçların uluslararası çok merkezli klinik araştırmalarının kaydı
Çalışma Listesi: Çalışmak 1: Başlık: A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy Recruitment: Recruiting Study Results: No Results Available Conditions: Kanser|Katarakt|Düşük Kemik Mineral Yoğunluğu|Osteopeni|Osteoporoz|Prostate Cancer Interventions: Biyolojik: Denosumab|Biyolojik: Placebo URL: http://ClinicalTrials.gov/show/NCT00925600 Study 2: Başlık: Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection Recruitment: Recruiting Study Results: No Results Available Conditions: Intra-Abdominal Infection Interventions: İlaç: Moksifloksasin (Avelox, BAY12-8039)|İlaç: Ertapenem, Amoxicillin/clavulanate URL: http://ClinicalTrials.gov/show/NCT01069900 Study 3: Başlık: A Study of LY2140023 in Patients With Schizophrenia Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: İlaç: LY2140023|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT01307800 Study 4: Başlık: Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Recruitment: Recruiting Study Results: No Results Available Conditions: Venous Thrombosis Interventions: İlaç: Enoksaparin|İlaç: varfarin|İlaç: Apiksaban için plasebo|İlaç: Enoksaparin için plasebo|İlaç: Varfarin için plasebo|İlaç: apixaban URL: http://ClinicalTrials.gov/show/NCT00643201 Study 5: Başlık: Mantık - ErbB2'de Lapatinib Optimizasyon Çalışması (HER2) Pozitif Mide Kanseri: A Aşama III Küresel, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib Recruitment: Recruiting Study Results: No Results Available Conditions: veya Lokal İlerlemiş Metastaz Nedeniyle Rezeke Edilemeyen Gastro-özofageal Bağlantı Adenokarsinomu, veya Lokal Olarak Tekrarlayan Hastalık.|ErbB2 (HER2) Güçlendirilmiş Mide|neoplazmalar, Gastrointestinal Sistem|Esophageal Interventions: İlaç: Lapatinib|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT00680901 Study 6: Başlık: Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: İleri Meme Kanseri|Breast Cancer Interventions: İlaç: Neratinib|İlaç: Lapatinib|İlaç: Capecitabine URL: http://ClinicalTrials.gov/show/NCT00777101 Study 7: Başlık: Açık etiket, Rastgele, Etkinliğin Değerlendirilmesine Yönelik Çok Merkezli Faz IIIb Çalışması, Safety and Tolerance of BERIPLEX® P/N Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical or Urgent Invasive Procedure Recruitment: Recruiting Study Results: No Results Available Conditions: Reversal of Coagulopathy Interventions: Biyolojik: Beriplex® P/N|Biyolojik: Fresh frozen plasma URL: http://ClinicalTrials.gov/show/NCT00803101 Study 8: Başlık: Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing Remitting Multiple Sclerosis Interventions: İlaç: İnterferon b 1a|İlaç: DAC HYP URL: http://ClinicalTrials.gov/show/NCT01064401 Study 9: Başlık: IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Renal Cell Carcinoma Interventions: İlaç: Sunitinib|Biyolojik: IMA901 artı GM-CSF|İlaç: Cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01265901 Study 10: Başlık: A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: URL'si: http://ClinicalTrials.gov/show/NCT01394601 Study 11: Başlık: Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function Recruitment: Recruiting Study Results: No Results Available Conditions: Kardiyovasküler Hastalıklar|Kalp Hastalıkları|Kalp yetmezliği, Congestive Interventions: İlaç: Aldosteron Antagonisti (spironolakton)|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT00094302 Study 12: Başlık: Bir Aşama 3 Brentuksimab Vedotin Çalışması (SGN-35) Kök Hücre Nakli Sonrası Rezidüel Hodgkin Lenfoma Riski Yüksek Olan Hastalarda (AETHERA Davası) işe alım: Recruiting Study Results: No Results Available Conditions: Hastalık, Hodgkin Interventions: İlaç: brentuksimab vedotin|İlaç: placebo URL: http://ClinicalTrials.gov/show/NCT01100502 Study 13: Başlık: Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures Recruitment: Recruiting Study Results: No Results Available Conditions: Nöbetler|Epilepsi|Partial-Onset Seizures Interventions: İlaç: Retigabine IR URL: http://ClinicalTrials.gov/show/NCT01227902 Study 14: Başlık: A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: İlaç: LY2127399|İlaç: Plasebo her 2 haftalar|İlaç: Plasebo her 4 weeks URL: http://ClinicalTrials.gov/show/NCT01198002 Study 15: Başlık: Eniluracil Çalışması + 5-Florourasil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Breast Cancer Interventions: İlaç: Enilurasil|İlaç: 5-Florourasil|İlaç: Lökovorin|İlaç: Capecitabine URL: http://ClinicalTrials.gov/show/NCT01231802 Study 16: Başlık: A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine Recruitment: Recruiting Study Results: No Results Available Conditions: Tümör|Pain Interventions: İlaç: CG5503 IS|İlaç: CG5503 ile eşleşecek plasebo|İlaç: Morfin Sülfat CR|İlaç: Placebo to match Morphine Sulphate CR URL: http://ClinicalTrials.gov/show/NCT00472303 Study 17: Başlık: Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: İlaç: ATN-103|İlaç: ATN-103 URL: http://ClinicalTrials.gov/show/NCT01063803 Study 18: Başlık: Subkütanöz ve İntravenöz MabThera'yı Karşılaştırmaya Yönelik Bir Çalışma (Rituksimab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia Recruitment: Recruiting Study Results: No Results Available Conditions: Lenfositik Lösemi, Chronic Interventions: İlaç: rituksimab [MabThera]|İlaç: rituksimab [MabThera]|İlaç: rituksimab [MabThera]|İlaç: Fludarabin|İlaç: Cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01292603 Study 19: Başlık: A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection Recruitment: Recruiting Study Results: No Results Available Conditions: Kronik Hepatit B Virüsü, Pediatric Interventions: İlaç: Entekavir|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT01079806 Study 20: Başlık: Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia Recruitment: Recruiting Study Results: No Results Available Conditions: Alopesi|Androgenetic Alopecia Interventions: İlaç: 1mg Finasterid aktif|İlaç: 0.02mg dutasterid|İlaç: 0.1mg dutasterid|İlaç: 0.5mg dutasterid|İlaç: Finasterid plasebo|İlaç: Dutasteride placebo URL: http://ClinicalTrials.gov/show/NCT01231607 Study 21: Başlık: Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Recruitment: Recruiting Study Results: No Results Available Conditions: Atriyal fibrilasyon|Aritmi|Felç Önleme|Mortality Interventions: Cihaz: Sol atriyal ablasyon|İlaç: Rate or Rhythm Control Therapy URL: http://ClinicalTrials.gov/show/NCT00911508 Study 22: Başlık: Tipe Sahip Bireylerde Alogliptinin Kardiyovasküler Sonuçları Çalışması 2 Diabetes and Acute Coronary Syndrome Recruitment: Recruiting Study Results: No Results Available Conditions: Diyabet Mellitus, Tip 2|Acute Coronary Syndrome Interventions: İlaç: Alogliptin|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT00968708 Study 23: Başlık: Tiotropiumun Değerlendirilmesi 2.5 Ve 5 Plasebo ve Salmeterol HydroFluoroAlkan ile Karşılaştırıldığında Respimat® İnhaler Aracılığıyla Günde Bir Kez Verilen Mcg (HFA) Ölçülü Doz Solunum Cihazı (MDI) (50 Mcg Günde İki Kez) in Patient With Moderate Persistent Asthma I Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: İlaç: Plasebo|İlaç: Plasebo|İlaç: Plasebo|İlaç: Plasebo|İlaç: Plasebo|İlaç: 50 mcg salmeterol HFA MDI|İlaç: 5 mcg tiotropium Respimat®|İlaç: 2.5 mcg tiotropium Respimat® URL: http://ClinicalTrials.gov/show/NCT01172808 Study 24: Başlık: Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatocellular Carcinoma Interventions: İlaç: sorafenib|Biyolojik: mapatumumab URL: http://ClinicalTrials.gov/show/NCT01258608 Study 25: Başlık: PD'li veya PD'siz Letrozol Çalışması 0332991 For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: İlaç: PD 0332991|İlaç: letrozol|İlaç: letrozole URL: http://ClinicalTrials.gov/show/NCT00721409 Study 26: Başlık: Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin Recruitment: Recruiting Study Results: No Results Available Conditions: Akciğer Kanseri - Non Small Cell Interventions: İlaç: İpilimumab|İlaç: Plasebo|İlaç: Paklitaksel|İlaç: Carboplatin URL: http://ClinicalTrials.gov/show/NCT01285609 Study 27: Başlık: Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Alzheimer Disease Interventions: İlaç: bapineuzumab|İlaç: bapineuzumab|İlaç: placebo URL: http://ClinicalTrials.gov/show/NCT00667810 Study 28: Başlık: Etkililik Çalışması & B Hücreli KLL'li Yaşlı Hastalarda İlk Basamak Tedavi Olarak Lenalidomid ve Klorambucil'in Güvenliği (ORIGIN Denemesi) işe alım: Recruiting Study Results: No Results Available Conditions: B Hücreli Kronik Lenfositik Lösemi (B-CLL) Müdahaleler: İlaç: Lenalidomid|İlaç: Chlorambucil URL: http://ClinicalTrials.gov/show/NCT00910910 Study 29: Başlık: MabThera Üzerine Bir Araştırma (Rituksimab) in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia And Favorable Somatic Status Recruitment: Recruiting Study Results: No Results Available Conditions: Lenfositik Lösemi, Chronic Interventions: İlaç: rituksimab [MabThera]|İlaç: fludarabin|İlaç: cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01271010 Study 30: Başlık: Bir Aromataz İnhibitörünün Lapatinib ile Kombinasyonunda Güvenlik ve Etkinliğini Karşılaştırmaya Yönelik Bir Çalışma, Hormon Reseptörü Pozitif Tedavisinde Trastuzumab veya Her İkisi, HER2+ Metastatic Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: neoplazmalar, Breast Interventions: İlaç: lapatinib|İlaç: trastuzumab|İlaç: Aromataz inhibitörü|İlaç: lapatinib URL: http://ClinicalTrials.gov/show/NCT01160211 Study 31: Başlık: Uzun Vadeli, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee Recruitment: Recruiting Study Results: No Results Available Conditions: Osteoarthritis Interventions: İlaç: SD-6010|İlaç: SD-6010|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT00565812 Study 32: Başlık: BI üzerine çalışma 54903 (İnhale Kortikosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids Recruitment: Not yet recruiting Study Results: No Results Available Conditions: Asthma Interventions: İlaç: Plasebo eşleştirme Respimat|İlaç: Plasebo eşleştirme Respimat|İlaç: iş zekası 54903 MD|İlaç: iş zekası 54903 HD URL: http://ClinicalTrials.gov/show/NCT01458912 Study 33: Başlık: Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure Recruitment: Recruiting Study Results: No Results Available Conditions: Heart Failure Interventions: İlaç: Plasebo|İlaç: Omecamtiv mecarbil URL: http://ClinicalTrials.gov/show/NCT01300013 Study 34: Başlık: Study of Immunotherapy to Treat Advanced Prostate Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Prostate Cancer Interventions: İlaç: İpilimumab|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT00861614 Study 35: Başlık: Faz 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin Recruitment: Recruiting Study Results: No Results Available Conditions: Non-small Cell Lung Cancer Interventions: İlaç: Tavosept(BNP7787) sisplatin ve dosetaksel veya paklitaksel ile kombinasyon halinde|İlaç: Placebo in combination with cisplatin and docetaxel or paclitaxel URL: http://ClinicalTrials.gov/show/NCT00966914 Study 36: Başlık: Bir Etkinlik, Emniyet, Tip Hastalarda Canagliflozin ve Tolerabilite Çalışması 2 Diabetes Mellitus Who Have Moderate Renal Impairment Recruitment: Recruiting Study Results: No Results Available Conditions: Diyabet Mellitus, Tip 2|Renal Insufficiency Interventions: İlaç: Canagliflozin 100 mg|İlaç: Canagliflozin 300 mg|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT01064414 Study 37: Başlık: ACT-293987 in Pulmonary Arterial Hypertension Recruitment: Recruiting Study Results: No Results Available Conditions: Pulmonary Arterial Hypertension Interventions: İlaç: ACT-293987|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT01106014 Study 38: Başlık: RoActemra/Actemra'nın Subkutan ve İntravenöz Uygulamasının Karşılaştırıldığı Bir Çalışma (Tosilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: İlaç: tocilizumab [RoActemra/Actemra]|İlaç: tocilizumab [RoActemra/Actemra]|İlaç: plasebo|İlaç: plasebo|İlaç: Hastalığı değiştirici antiromatizmal ilaçlar (DMARD'lar) URL'si: http://ClinicalTrials.gov/show/NCT01194414 Study 39: Başlık: Romatoid Artrit Tedavisinde Fostamatinibin Uzun Dönem Güvenliği ve Etkinliğinin Değerlendirilmesi (RA) işe alım: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: İlaç: Fostamatinib|İlaç: Fostamatinib|İlaç: Fostamatinib URL: http://ClinicalTrials.gov/show/NCT01242514 Study 40: Başlık: RED-HF™ Denemesi - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial Recruitment: Recruiting Study Results: No Results Available Conditions: Kalp yetmezliği|Anemi|Kardiyovasküler Hastalık|Ventriküler Disfonksiyon|Congestive Heart Failure Interventions: İlaç: Darbepoetin alfa|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT00358215 Study 41: Başlık: AVAPERL1 Çalışması: Avastin Üzerine Bir Araştırma (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Non-Small Cell Lung Cancer Interventions: İlaç: bevacizumab [keşfettim]|İlaç: pemetrekset|İlaç: cisplatin URL: http://ClinicalTrials.gov/show/NCT00961415 Study 42: Başlık: Kısmen Kontrollü Astımı Olan Erişkin Hastalarda ACT-129968 Çalışması. işe alım: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: İlaç: ACT-129968|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT01225315 Study 43: Başlık: Lokal İleri Düzeyde İkinci Basamak Tedavi Olarak Ixabepilone Üzerine Bir Çalışma, Recurrent or Metastatic Endometrial Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Endometrial Cancer Interventions: İlaç: Xabepilone|İlaç: Doksorubisin|İlaç: Paclitaxel URL: http://ClinicalTrials.gov/show/NCT00883116 Study 44: Başlık: Aksitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Kidney Neoplasms Interventions: İlaç: Aksitinib (AG-013736)|İlaç: Sorafenib URL: http://ClinicalTrials.gov/show/NCT00920816 Study 45: Başlık: GSK1349572'ye Karşı Raltegravir Karşılaştırması (RAL) Antiretroviral Deneyimli Kişilerde Araştırmacı Tarafından Seçilen Arka Plan Rejimi ile, Integrase Inhibitor-Naive Adults Recruitment: Recruiting Study Results: No Results Available Conditions: Enfeksiyon, Human Immunodeficiency Virus Interventions: İlaç: GSK1349572|İlaç: Raltegravir|İlaç: GSK1349572 Plasebo|İlaç: Raltegravir Placebo URL: http://ClinicalTrials.gov/show/NCT01231516 Study 46: Başlık: BI'nın Yenileme Çalışması 201335 Tedavi Deneyimli Genotipte Pegile İnterferon-alfa ve Ribavirin ile Kombinasyonda 1 Hepatitis C Infected Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatitis C Interventions: İlaç: PegIFN/RBV|İlaç: iş zekası 201335 URL'si: http://ClinicalTrials.gov/show/NCT01330316 Study 47: Başlık: Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Multipl skleroz|Relapsing-remitting Interventions: İlaç: AIN457|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT01051817 Study 48: Başlık: Xolair'in Etkinliği ve Güvenliği Üzerine Bir Araştırma (Omalizumab) Kronik İdiyopatik Ürtikeri Olan Hastalarda (UKÜ)/Kronik Spontan Ürtiker (CSU) Antihistamin Tedavisine Rağmen Semptomatik Kalanlar (H1) işe alım: Recruiting Study Results: No Results Available Conditions: Chronic Idiopathic Urticaria Interventions: İlaç: omalizumab|İlaç: placebo URL: http://ClinicalTrials.gov/show/NCT01287117 Study 49: Başlık: İzavukonazol (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections Recruitment: Recruiting Study Results: No Results Available Conditions: Mikozlar|Kandidiyaz, İnvaziv|Candidemia Interventions: İlaç: İzavukonazol|İlaç: Kaspofungin|İlaç: Voriconazole URL: http://ClinicalTrials.gov/show/NCT00413218 Study 50: Başlık: BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Yumurtalık Neoplazmaları|Peritoneal Neoplasms Interventions: İlaç: BIBF 1120|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT01015118 Study 51: Başlık: İmmünojenisite ve Farmakokinetik (PK) Tekrarlayan Düzelen Multipl Sklerozda DAC HYP Önceden Doldurulmuş Şırınganın İncelenmesi (RRMS) işe alım: Recruiting Study Results: No Results Available Conditions: Relapsing Remitting Multiple Sclerosis Interventions: Biyolojik: Daclizumab High Yield Process prefilled syringe URL: http://ClinicalTrials.gov/show/NCT01462318 Study 52: Başlık: Study in Adolescents With Schizophrenia or Bipolar Disorder Recruitment: Recruiting Study Results: No Results Available Conditions: Bipolar I Bozukluğu|Schizophrenia Interventions: İlaç: Olanzapin|Davranışsal: Standart davranışsal ağırlık müdahalesi|Davranışsal: Intense behavioral weight intervention URL: http://ClinicalTrials.gov/show/NCT00982020 Study 53: Başlık: ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation Recruitment: Recruiting Study Results: No Results Available Conditions: Coronary Artery Disease Interventions: İlaç: RVX000222|İlaç: Placebo RVX000222 URL: http://ClinicalTrials.gov/show/NCT01067820 Study 54: Başlık: Optimum Düzeyde Kontrol Edilmeyen Şizofreni Belirtileri Olan Hastalarda RO4917838 Üzerine Bir Çalışma (NN25307) işe alım: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: İlaç: RO4917838|İlaç: RO4917838|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT01235520 Study 55: Başlık: Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Subjects With PHPT Unable to Undergo Parathyroidectomy Recruitment: Recruiting Study Results: No Results Available Conditions: Hiperparatiroidizm, Primary Interventions: İlaç: sinakalset HCl|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT00975221 Study 56: Başlık: Romatoid Artritli Hastalarda Fostamatinib'in İki Doz Rejiminin Etkinliğinin Plaseboya Göre Değerlendirilmesi (RA) Metotreksat Alan Ama Yanıt Vermeyenler. işe alım: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: İlaç: fostamatinib|İlaç: fostamatinib|İlaç: plasebo, fostamatinib URL: http://ClinicalTrials.gov/show/NCT01197521 Study 57: Başlık: Retigabinin Hızlı Salımına İlişkin Uzun Dönemli Güvenlik Çalışması (VE) Kısmi Başlangıçlı Nöbetler Olan Erişkinlerin Tedavisinde Yardımcı Tedavi Olarak (POS). işe alım: Recruiting Study Results: No Results Available Conditions: Nöbetler|Epilepsi|Partial-Onset Seizures Interventions: İlaç: Retigabine IR URL: http://ClinicalTrials.gov/show/NCT01336621 Study 58: Başlık: ErbB2'de Lapatinib Artı Kapesitabine Karşı Trastuzumab Artı Kapesitabin (HER2) Pozitif Metastatik Meme Kanseri. işe alım: Recruiting Study Results: No Results Available Conditions: Metastatik Meme Kanseri|Metastazlar, Brain Interventions: İlaç: kapesitabin|İlaç: lapatinib|İlaç: trastuzumab URL: http://ClinicalTrials.gov/show/NCT00820222 Study 59: Başlık: STREAM-Stratejik Reperfüzyon (Tenekteplaz ve Antitrombotik Tedavi ile) Early After Myocardial Infarction Recruitment: Recruiting Study Results: No Results Available Conditions: Myocardial Infarction Interventions: İlaç: tenekteplaz|İlaç: enoksaparin|İlaç: klopidogrel|Prosedür: kateterizasyon|Prosedür: primary PCI URL: http://ClinicalTrials.gov/show/NCT00623623 Study 60: Başlık: İnterferon Beta-1a ile Karşılaştırmalı Ocrelizumab Çalışması (Rebif) in Patients With Relapsing Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Multipl skleroz, Relapsing-Remitting Interventions: İlaç: ocrelizumab|İlaç: Rebif|İlaç: ocrelizumab plasebo|İlaç: Rebif placebo URL: http://ClinicalTrials.gov/show/NCT01247324 Study 61: Başlık: KAROLİNA: Tip Hastalarda Linagliptin ve Glimepiridin Kardiyovasküler Sonuç Çalışması 2 Diabetes Recruitment: Recruiting Study Results: No Results Available Conditions: Diyabet Mellitus, Tip 2 Müdahaleler: İlaç: linagliptin|İlaç: glimepiride URL: http://ClinicalTrials.gov/show/NCT01243424 Study 62: Başlık: PANORAMA Observational Study Recruitment: Recruiting Study Results: No Results Available Conditions: Aritmi|Kalp Pili, Yapay|Defibrilatörler, Implantable Interventions: Cihaz: Kalp Pili, Defibrilatör, pacemaker lead URL: http://ClinicalTrials.gov/show/NCT00382525 Study 63: Başlık: GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Tümör Antijen-pozitif Küçük Hücreli Dışı Akciğer Kanseri|Akciğer Kanseri, Non-Small Cell Interventions: Biyolojik: GSK1572932A Antijene Spesifik Kanser İmmünoterapötik|Biyolojik: Placebo Control URL: http://ClinicalTrials.gov/show/NCT00480025 Study 64: Başlık: Haftada Bir NeoRecormon Tedavisine Yaşam Kalitesi ve Tedavi Yanıtı Üzerine Bir Araştırma (Epoetin Beta) Solid ve Lenfoid Maligniteli Anemik Hastalarda Tedavi. işe alım: Recruiting Study Results: No Results Available Conditions: Anemia Interventions: İlaç: epoetin beta [NeoRecormon]|İlaç: epoetin beta [NeoRecormon] URL'si: http://ClinicalTrials.gov/show/NCT00776425 Study 65: Başlık: K Vitamini Antagonistine Karşı Uzun Süreli Innohep® Tedavisi (Varfarin) Venöz Tromboembolizmin Tedavisinde (VTE) in Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Venous Thromboembolism Interventions: İlaç: Varfarin|İlaç: Innohep® URL: http://ClinicalTrials.gov/show/NCT01130025 Study 66: Başlık: Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia Recruitment: Recruiting Study Results: No Results Available Conditions: HIV Interventions: İlaç: HIV therapy URL: http://ClinicalTrials.gov/show/NCT01275625 Study 67: Başlık: LUX-Göğüs 2; HER2'de Afatinib (İnsan Epidermal Büyüme Faktörü Reseptörü)-Treatment Failures Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Neoplasms Interventions: İlaç: Afatinib 40 mg günde bir kez (İLE İLGİLİ)|İlaç: Vinorelbin 25 mg/m2 haftalık|İlaç: Paklitaksel 80 mg/m2 weekly URL: http://ClinicalTrials.gov/show/NCT01271725 Study 68: Başlık: Onartuzumab Üzerine Bir Çalışma (MetMAb) Tarceva ile Kombinasyonda (Erlotinib) İleri veya Metastatik Hastalık İçin Kemoterapi Gören Met Tanısal Pozitif Küçük Hücreli Dışı Akciğer Kanseri Hastalarında (MetLung) işe alım: Not yet recruiting Study Results: No Results Available Conditions: Non-Small Cell Lung Cancer Interventions: İlaç: onartuzumab [MetMAb]|İlaç: erlotinib [Tarçeva]|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT01456325 Study 69: Başlık: Dosetakselin Faz III Çalışması + Ramucirumab or Placebo in Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Biyolojik: ramucirumab (IMC-1121B)|İlaç: doketaksel|Diğer: placebo URL: http://ClinicalTrials.gov/show/NCT00703326 Study 70: Başlık: ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis -Extension Study Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing-remitting Multiple Sclerosis Interventions: İlaç: ACT-128800|İlaç: ACT-128800|İlaç: ACT-128800 URL: http://ClinicalTrials.gov/show/NCT01093326 Study 71: Başlık: Çift kör, Plasebo kontrollü, 2-Hafif ve Orta Derecede Alzheimer Hastalarının Tedavisinde Kullanılan Galantamin Çalışması. işe alım: Recruiting Study Results: No Results Available Conditions: Alzheimer Hastalığı|Demans, Alzheimer Type Interventions: İlaç: Galantamin|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT00679627 Study 72: Başlık: Psoriasisli Adölesan Hastalarda Ustekinumab'ın Güvenilirliği ve Etkinliği Üzerine Bir Araştırma (CADMUS) işe alım: Recruiting Study Results: No Results Available Conditions: Psoriasis Interventions: Biyolojik: ustekinumab/plasebo|Biyolojik: ustekinumab/plasebo|Biyolojik: ustekinumab/placebo URL: http://ClinicalTrials.gov/show/NCT01090427 Study 73: Başlık: PEARL Schizophrenia Maintenance Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: İlaç: Lurasidon|İlaç: Matching Placebo URL: http://ClinicalTrials.gov/show/NCT01435928 Study 74: Başlık: Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery Recruitment: Recruiting Study Results: No Results Available Conditions: Preterm Birth Interventions: İlaç: Hidroksiprogesteron Kaproat Enjeksiyonu, 250mg/mL|İlaç: Vehicle URL: http://ClinicalTrials.gov/show/NCT01004029 Study 75: Başlık: Tip Olarak Aleglitazar Üzerine Bir Araştırma 2 Diabetes Patients With Moderate Renal Impairment Recruitment: Recruiting Study Results: No Results Available Conditions: Diyabet Mellitus, Tip 2 Müdahaleler: İlaç: Aleglitazar|İlaç: pioglitazone URL: http://ClinicalTrials.gov/show/NCT01043029 Study 76: Başlık: Kronik Obstrüktif Akciğer Hastalığında Roflumilast (KOAH) Uzun Etkili β2-agonistlerin Sabit Kombinasyonlarıyla Tedavi Edilen Hastalar (İKİ) ve İnhale Glukokortikosteroid (ICS) işe alım: Recruiting Study Results: No Results Available Conditions: Chronic Obstructive Pulmonary Disease Interventions: İlaç: Roflumilast'tan|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT01329029 Study 77: Başlık: Bendamustine'nin Bendamustine+RO5072759 ile Karşılaştırıldığında Etkinliğini ve Güvenliğini Araştırmaya Yönelik Bir Çalışma (GA101) Rituximab'a Dirençli Hastalarda, Indolent Non-Hodgkin's Lymphoma Recruitment: Recruiting Study Results: No Results Available Conditions: Non-Hodgkin's Lymphoma Interventions: İlaç: sahip olmalıyız|İlaç: RO5072759 URL: http://ClinicalTrials.gov/show/NCT01059630 Study 78: Başlık: Etkinliği ve Güvenliği 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: İlaç: 2.5 mcg tiotropium Respimat|İlaç: plasebo Respimat|İlaç: 2.5 mcg tiotropium Respimat URL: http://ClinicalTrials.gov/show/NCT01257230 Study 79: Başlık: TMC125IFD3002 - KEMAN Çalışması: Etravirinin Tolere Edilebilirliğini Değerlendirmek İçin, PharmacOkinetics With Other AntiretroviraLs In TreatmeNt Experienced Patients Recruitment: Recruiting Study Results: No Results Available Conditions: HIV Interventions: İlaç: etravirine URL: http://ClinicalTrials.gov/show/NCT01422330 Study 80: Başlık: Study of Paclitaxel in Patients With Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Epitelyal Yumurtalık Kanseri|Birincil Periton Kanseri|Fallopian Tube Cancer Interventions: İlaç: Paklical®|İlaç: Taxol® URL: http://ClinicalTrials.gov/show/NCT00989131 Study 81: Başlık: Avastin İlavesine İlişkin Bir Araştırma (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Ovarian Cancer Interventions: İlaç: bevacizumab [keşfettim]|İlaç: karboplatin|İlaç: Paclitaxel URL: http://ClinicalTrials.gov/show/NCT01239732 Study 82: Başlık: Asthma in Children Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: URL'si: http://ClinicalTrials.gov/show/NCT01286532 Study 83: Başlık: MabThera Üzerine Bir Araştırma (Rituksimab) Tek Bir Anti-TNF İnhibitörüne Yetersiz Yanıt Veren Romatoid Artritli Hastalarda. işe alım: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: İlaç: rituksimab [MabThera/Rituxan]|İlaç: Methotrexate URL: http://ClinicalTrials.gov/show/NCT00576433 Study 84: Başlık: İnterferon Beta-1a ile Karşılaştırmalı Ocrelizumab Çalışması (Rebif) in Patients With Relapsing Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Multipl skleroz, Relapsing-Remitting Interventions: İlaç: ocrelizumab|İlaç: Rebif|İlaç: ocrelizumab plasebo|İlaç: Rebif placebo URL: http://ClinicalTrials.gov/show/NCT01412333 Study 85: Başlık: İlerlemiş veya Metastatik Küçük Hücreli Dışı Akciğer Kanseri Olan Bireylerde ABT-869 ile Kombinasyon halinde Karboplatin/Paklitaksel Çalışması (KHDAK) işe alım: Recruiting Study Results: No Results Available Conditions: Advanced or Metastatic Non-Small Cell Lung Cancer Interventions: İlaç: ABT-869|İlaç: ABT-869 için Plasebo|İlaç: ABT-869 URL: http://ClinicalTrials.gov/show/NCT00716534 Study 86: Başlık: Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Lucrin Depot in Patients With Advanced Prostate Cancer in Russia Recruitment: Recruiting Study Results: No Results Available Conditions: Prostate Cancer Interventions: URL'si: http://ClinicalTrials.gov/show/NCT01320735 Study 87: Başlık: CNTO'nun Güvenliği ve Etkinliği Üzerine Bir Araştırma 328 in Combination With Best Supportive Care Compared to Best Supportive Care in Patients With Multicentric Castleman's Disease Recruitment: Recruiting Study Results: No Results Available Conditions: Castleman's Disease Interventions: Diğer: Plasebo|İlaç: CNTO 328 URL'si: http://ClinicalTrials.gov/show/NCT01024036 Study 88: Başlık: SAR153191'in değerlendirilmesi(REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: İlaç: SAR153191 (REGN88)|İlaç: placebo URL: http://ClinicalTrials.gov/show/NCT01061736 Study 89: Başlık: A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids Recruitment: Recruiting Study Results: No Results Available Conditions: Kidney Transplantation Interventions: İlaç: Advagraf|İlaç: Mikofenolat Mofetil|İlaç: Simulect|İlaç: Corticosteroids URL: http://ClinicalTrials.gov/show/NCT01304836 Study 90: Başlık: Rituksimab Kombinasyonunun Çalışması, Siklofosfamid, Doksorubisin, VELCADE, ve Prednizon veya Rituksimab, Siklofosfamid, Doksorubisin, Vinkristin, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma Recruitment: Recruiting Study Results: No Results Available Conditions: Mantle Cell Lymphoma Interventions: İlaç: Rituksimab, Siklofosfamid, Doksorubisin, VELCADE, ve Prednizon|İlaç: Rituksimab, Siklofosfamid, Doksorubisin, Vincristine and Prednisone URL: http://ClinicalTrials.gov/show/NCT00722137 Study 91: Başlık: Çift kör, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects Recruitment: Recruiting Study Results: No Results Available Conditions: DLBCL Interventions: Biyolojik: TL011|Biyolojik: Rituximab URL: http://ClinicalTrials.gov/show/NCT01205737 Study 92: Başlık: Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: İlaç: Sorafenib(Nexavar, BAY43-9006) / Kapesitabin|İlaç: Plasebo / Capecitabine URL: http://ClinicalTrials.gov/show/NCT01234337 Study 93: Başlık: RoActemra/Actemra Üzerine Bir Araştırma (Tosilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors Recruitment: Recruiting Study Results: No Results Available Conditions: Kardiyovasküler Hastalık, Rheumatoid Arthritis Interventions: İlaç: tocilizumab [RoActemra/Actemra]|İlaç: etanercept URL: http://ClinicalTrials.gov/show/NCT01331837 Study 94: Başlık: Pregabalin Versus Levetiracetam In Partial Seizures Recruitment: Recruiting Study Results: No Results Available Conditions: Partial Seizures Interventions: İlaç: pregabalin|İlaç: levetiracetam URL: http://ClinicalTrials.gov/show/NCT00537238 Study 95: Başlık: Pimavanserinin Güvenliği ve Tolere Edilebilirliği Üzerine Bir Araştırma (ACP-103) in Patients With Parkinson's Disease Psychosis Recruitment: Recruiting Study Results: No Results Available Conditions: Parkinson's Disease Psychosis Interventions: İlaç: pimavanserin tartarat (ACP-103) URL'si: http://ClinicalTrials.gov/show/NCT00550238 Study 96: Başlık: Kardiyovasküler Olay Düşürücü Denemeye İlişkin Eksenatid Çalışması (EXSCEL): Tip Hastalarda Haftada Bir Eksenatid Tedavisi Sonrası Kardiyovasküler Sonuçların Değerlendirilmesine Yönelik Bir Deneme 2 Diabetes Mellitus Recruitment: Recruiting Study Results: No Results Available Conditions: Tip 2 Diabetes Mellitus Interventions: İlaç: Eksenatid Haftada Bir Kez|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT01144338 Study 97: Başlık: A Study of LY2127399 in Patients With Systemic Lupus Erythematosus Recruitment: Recruiting Study Results: No Results Available Conditions: Sistemik Lupus Eritematozus|Bağ Dokusu Hastalığı|Autoimmune Disease Interventions: İlaç: LY2127399|İlaç: Plasebo her 2 haftalar|İlaç: Plasebo her 4 weeks URL: http://ClinicalTrials.gov/show/NCT01205438 Study 98: Başlık: Study of FP-1039 in Subjects With Endometrial Cancers Recruitment: Recruiting Study Results: No Results Available Conditions: Endometrial Cancers With FGFR2 Mutations Interventions: İlaç: FP-1039 URL: http://ClinicalTrials.gov/show/NCT01244438 Study 99: Başlık: TMC435HPC3007 - Genotipte TMC435'in Faz III Denemesi 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatitis C Interventions: İlaç: TMC435|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT01281839 Study 100: Başlık: Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy Recruitment: Recruiting Study Results: No Results Available Conditions: Colorectal Cancer Interventions: İlaç: CS-7017|İlaç: Placebo URL: http://ClinicalTrials.gov/show/NCT00986440
Bilimsel Vaka İncelemesi
Mevcut klinik programların olup olmadığını anlamak ister misiniz?, son araştırma gelişmeleri, veya ortaya çıkan yaklaşımlar olabilir kişisel durumunuzla alakalı?
Sorunuzu bilimsel ekibimize gönderin. Birleşik Krallık'taki NBScience merkez ofisi, uluslararası tıp merkezleri ağı genelindeki araştırmaları koordine etmektedir., bilim adamları, ve uzman danışmanlar.
- Sağladığınız bilgilerin gözden geçirilmesi
- İlgili araştırma ve klinik program bilgileri
- Durumunuza odaklanmış net bir yanıt
Sonra ne olacak??
Sorunuzu gönderin, odaklanmış bir bilimsel inceleme almak, ve durumunuzla ilgili araştırma ve klinik programlar hakkında net bir yanıt alın.
Bilimsel incelemeniz şu şekilde hazırlanacaktır: Dr.. Helen Melnik,Doktora , kimin daha fazlasına sahip 25 yılların tecrübesi kök hücre araştırmalarında ve uluslararası klinik programlarda.
Hiçbir yükümlülük yok. Sorunuz gizli olarak incelenecektir.
Yalnızca eğitim ve araştırma bilgileri. Bu hizmet tıbbi tavsiye teşkil eder, teşhis, reçete, veya kişiselleştirilmiş tedavi önerisi.
